Stop The Bleeding: Sanofi-Aventis Looks To Sell A Generic Plavix In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
If a bioequivalent version of the clot buster launches in France, Sanofi is preparing to roll out its own generic version of clopidogrel.
You may also be interested in...
AstraZeneca's Brilique Approved In The EU
AstraZeneca's antiplatelet agent Brilique/Brilinta receives its first approval, but pricing negotiations will delay launch in most countries.
AstraZeneca's Brilique Approved In The EU
AstraZeneca's antiplatelet agent Brilique/Brilinta receives its first approval, but pricing negotiations will delay launch in most countries.
Health Reform Magnifies Payers' Invisible Place At The Licensing Table
Report from Licensing Executives Society meeting: Survey shows many already have taken action oncomparative effectiveness.